Lisata Therapeutics (LSTA) Projected to Post Earnings on Thursday

Lisata Therapeutics (NASDAQ:LSTA) is projected to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.76) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Lisata Therapeutics Trading Down 2.7 %

LSTA opened at $2.48 on Tuesday. The company has a market cap of $20.82 million, a P/E ratio of -0.99 and a beta of 1.14. Lisata Therapeutics has a 12 month low of $2.19 and a 12 month high of $4.20. The business’s 50-day moving average price is $2.97 and its 200-day moving average price is $2.93.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $15.00 target price on shares of Lisata Therapeutics in a research note on Wednesday, December 11th.

Lisata Therapeutics Company Profile

Lisata Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease.